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REDUCING OUTPATIENT BMT CLINIC VISIT TIMES
Cuthrell, P.,Michael,M.A., Vaughn, G., Detzel, J.,Maier, S., Davis, K.,
Herman, E., Flesch, L., Pomales, J., Craig, S., Alvey, P., Kirkendall, S.,
Hicks, B., Simon, T., Bierman, L., Harris, M., Shah, N., Filipovich, A.,
Davies, S. Cincinnati Children’s HospitalMedical Center, Cincinnati, OH
As our health care environment faces increasing costs, high de-
mands, and shifts towards outpatient care, facilities are forced to re-
assess their operations. To manage a successful clinic, a focus must
be placed on efficient yet safe patient care delivery. Patient satisfac-
tion plays an important part of this reassessment. In our pediatric
BMT clinic, patients receive a variety of clinical care support includ-
ing f/u exams, lab draws, central line care, short infusion therapies
and new patient consults. Literature review finds that most research
has focused on studying scheduling options to reduce visit times in
the outpatient setting. Our improvement project was focused on re-
ducing overall patient visit time through changes that impacted pa-
tient flow. An Improvement Science approach was initiated by staff
and initially they looked at average clinic visit times (time of arrival
to time of discharge) for new and follow-up visits in the BMT clinic
from January - March, 2010. The staff also looked at the past parent
satisfaction survey data from our outpatient pediatric BMT clinic
which revealed that 65% of families felt wait times in exam rooms
were not acceptable. The overall aim of this project focused on de-
creasing average clinic visit time for new and follow-up BMT pa-
tients by 25%. Key drivers were identified as accurately scheduled
provider templates, adequate staffing, clear role responsibilities/
team work, accurate communication handoff and timely discharge
documentation. Key interventions included placing an APN in the
clinic provider template, developing a FlowLeadRN role with triage
and implementing the pod nursing care delivery system. Visit time
data was extrapolated and placed on a run chart to show improve-
ments made throughout the last 6 months. Run chart data showed
a shift in the mean and a reduction in overall visit time for new
and follow-up patients. Median new visits were reduced from 241
to 221 minutes. The median follow-up visits were reduced from
209 to 167 minutes. Families, staff and physicians have commented
positively on the interventions. Consistent handoffs of care/commu-
nication have led to a safer environment for patients. We are con-
tinuing to test, implement and evaluate changes to reduce visit
time and increase family satisfaction as we work to meet the goals
set with this improvement project.111
PREVENTION OF DMSO-RELATED NAUSEA AND VOMITING BY PROPHY-
LACTIC ADMINISTRATION OF ONDANSETRON FOR PATIENTS RECEIVING
AUTOLOGOUS CRYOPRESERVED PERIPHERAL BLOOD STEM CELLS
Eisenberg, S.1 1Seattle Cancer Care Alliance, Seattle, WA
Background:DMSO(dimethyl sulfoxide) is frequently used as a cry-
opreservative for peripheral blood stem cells (PBSCs). Common side
effects of this chemical include nausea, vomiting, abdominal cramp-
ing, coughing and throat irritation. A comprehensive literature
search using PubMed and CINAHL failed to reveal any studies in-
vestigating the benefit of antiemetics for preventing or reducing
DMSO-induced nausea or vomiting.
Study design: A pilot study was conducted to determine whether
a single 16mg intravenous dose of ondansetron could decrease the
degree of nausea and episodes of emesis in patients receiving autol-
ogous PBSCs cryopreserved in DMSO. Fifty patients scheduled to
receive an autologous transplant in an ambulatory NCI-designated
comprehensive cancer center were enrolled. Nausea was rated usingthe MAASC nausea scale (0-10) at the following time points: upon
arrival to the Infusion Room, prior to the ondansetron administra-
tion, prior to each cryopreserved bag, and at the end of the last
bag. Episodes of emesis were documented. Results would be com-
pared to an (unpublished) study examining the side effects of
DMSO on 60 autologous HSCT patients previously conducted by
this investigator.
Results: Forty-nine patients were evaluable. Compared to the his-
torical control group, there were no statistically significant differ-
ences in nausea and vomiting when examining age, disease, gender,
and chemotherapy regimens. There was no correlation between in-
fusion rate and nausea scores, or between individual nausea scores
and those patients who vomited. A trend (p 5 0.05) was noted for
increased nausea scores as the number of bags increased.
Discussion: Only 9/49 (18%) of the study patients had nausea (p\
.0001) compared to 58% from the control group. In addition, only 9/
49 (18%) vomited compared to 33% in the control group.
Conclusion: Although this was a small, non-blinded pilot study, the
results suggest patients who received a single dose of intravenous on-
dansetron had significantly decreased nausea and vomiting during
cryopreserved stem cell infusions. A larger, double-blinded study is
warranted.112
END-OF-LIFE AND PALLIATIVE CARE IN BMT: NURSES NEED EDUCATION
AND SUPPORT
Sprouse, D.O., Thirlwell, S., Beaupierre, A., Lauersdorf, L. Moffitt Can-
cer Center, Tampa, FL
Recently, the Blood and Marrow Transplant (BMT) program at
our NCI-designated Cancer Center increased its inpatient capacity
by 80% and its nursing staff by 50%. Concurrently, treatment pro-
tocols expanded and patients with co-morbidities increased. These
factors have resulted in increased morbidity, mortality, and length
of stay and increased compassion fatigue among old and new BMT
nurses.
Two new BMT nurses expressed concern regarding peers’ com-
passion fatigue and a desire to educate about palliative care (PC)
and end of life (EOL). Partnering with the Clinical Nurse Specialist
(CNS) and Patient Care Manager, staff nurses initiated an EOL/PC
Committee with the goals of staff education and support. Education
has included journal article review and guests such as the Ethics
Committee Chair, Hospice Liaisons, and Palliative Care Nurse Ex-
perts. Members are encouraged to obtain ELNEC (End-of-Life
Nursing Education Consortium) or similar training. Attendees re-
ceive support through an open forum at each monthly meeting to
share concerns about patient deaths, life-threatening complications
or goals of care. Meeting discussions are facilitated by a CNS certi-
fied in Hospice and Palliative Care, ELNEC educators, hospice
nurses, social worker, and Psychiatric CNS. Discussions focus on
expression of emotions, problem-solving and nurse’s role at EOL.
EOL/PC Committee has grown from 4 to 27% of unit staff since
April 2009. Beyond direct education and support at meetings, issues
raised have resulted in care improvement initiatives. Outcomes in-
clude peer education regarding post-mortem care, collaboration
with Medical Leadership to improve communication about futile
care and presentation at Grand Rounds to elevate awareness of
EOL issues. Ongoing initiatives are to develop a tool to assess futility
of care, to identify a Palliative Care Resource Nurse for each shift
and to enhance nurse’s role in completion of Advance Directives.
The unit-based BMTEOL/PCCommittee has successfully raised
awareness and created a forum for discussion of PC and EOL issues.
Though we all strive for cure, we need to acknowledge and support
the reality that all transplants are not successful and are associated
with emotionally and physically devastating complications for the
patient, their family and BMT staff. On our unit, the BMT EOL/
PC Committee is a safe venue for nursing staff to acknowledge this
reality as well as an arena to improve the PC and EOL that we
provide.
